Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The oncogene BCL2 is a membrane protein that blocks a step in a pathway leading to apoptosis or programmed cell death. Additionally we are shipping BAG1 Proteins (18) and and many more products for this protein.
Showing 10 out of 136 products:
Human Polyclonal BAG1 Primary Antibody for WB - ABIN2477577
Broström, Kronberg, Németh, Oxelbäck: The effect of shoulder muscle training in patients with recurrent shoulder dislocations. in Scandinavian journal of rehabilitation medicine 1992
Show all 4 Pubmed References
Human Polyclonal BAG1 Primary Antibody for WB - ABIN2477576
Liman, Ganesan, Dohm, Krajewski, Reed, Bähr, Wouters, Kermer: Interaction of BAG1 and Hsp70 mediates neuroprotectivity and increases chaperone activity. in Molecular and cellular biology 2005
Show all 4 Pubmed References
Human Polyclonal BAG1 Primary Antibody for IHC, IHC (p) - ABIN4282935
Aust, Pils, Polterauer, Horvat, Cacsire Castillo-Tong, Pils, Dudek, Schmid, Speiser, Reinthaller, Grimm: Expression of Bcl-2 and the antiapoptotic BAG family proteins in ovarian cancer. in Applied immunohistochemistry & molecular morphology : AIMM 2013
Here the authors show that the AF-1 (show EFNA5 Antibodies) domain of AR is bound by the cochaperone Bag-1L.
Over expression of BAG-1 may be a biomarker for cisplatin resistance in patients with primary or recurrent head and neck squamous cell carcinoma.
Increased BAG-1 by PD-L1 (show CD274 Antibodies) confers resistance to tyrosine kinase (show TXK Antibodies) inhibitor in non-small cell lung cancer via persistent activation of ERK (show EPHB2 Antibodies) signaling.
BAG-4/SODD (show BAG4 Antibodies), HSP70 (show HSP70 Antibodies), and HSP90 (show HSP90 Antibodies) are potential prognostic markers in node-negative breast carcinoma that merit further research.
interaction with Bag1 then shifts hERG (show KCNH2 Antibodies) degradation to the membrane-anchored E3 ligase TRC8 (show RNF139 Antibodies) and its E2-conjugating enzyme Ube2g2 (show UBE2G2 Antibodies), as determined by siRNA screening
These results suggest that Bag1 and Bag3 (show BAG3 Antibodies) control the stability of the Hsc70 (show HSPA8 Antibodies)-client complex using at least two distinct protein-protein contacts, providing a previously under-appreciated layer of molecular regulation in the human Hsc70 (show HSPA8 Antibodies) system.
Taken together, these data indicate that Bag-1 up-regulation is required to maintain apoptosis resistance in human cytomegalovirus-infected cells.
the combined effects of BAG-1 and XPD (show ERCC2 Antibodies) polymorphisms on chemotherapy sensitivity and survival in patients with advanced non-small-cell lung cancer, which might be the important predictive markers for platinum-based chemotherapy efficacy.
Bag-1 indirectly affects cell survival through c-Myc (show MYC Antibodies) activated signalling that causes elevation of ornithine decarboxylase (show ODC1 Antibodies) levels, leading to an increase of the polyamine content.
Overexpression of miR (show MLXIP Antibodies)-138 inhibited cell proliferation by directly suppressing the expression of Bag-1.
that BAG-1L over-expression protects against hypoxia/re-oxygenation injury, at least in part, by interacting with HSP70 (show HSP70 Antibodies), and by accelerating the activation of PI3K/AKT (show AKT1 Antibodies) pathways
These studies demonstrate for the first time the significance of BAG-1-mediated protein-protein interactions.
The BAG-1 stabilizes F508del-CFTR by direct binding, probably competing out ubiquitin to partially avoid its proteasomal degradation.
The membrane form of heparin binding EGF-like growth factor (show HBEGF Antibodies) (ProHB-EGF (show EGF Antibodies)) is most likely able to trigger the nuclear translocation of BAG-1 in keeping its level high.
Hemoxygenase (show HMOX1 Antibodies) 1 deficiency provoked diminished Bag-1 level upon LPS (show TLR4 Antibodies) treatment
this study first reported the solution structure of mBAG-1 (show LRRC4 Antibodies)-UBH and the growth factor precursor-interacting motif on the protein.
Bag-1 proteins function as regulators of the action of selective transcription factors.
during development of mouse autopods, BAG-1 expression is downregulated upon the initiation of interdigital apoptosis (BAG-1)
Bag1 is a regulator and marker of neuronal differentiation
BAG1 displays potent neuroprotective activity in vivo against stroke.
The oncogene BCL2 is a membrane protein that blocks a step in a pathway leading to apoptosis or programmed cell death. The protein encoded by this gene binds to BCL2 and is referred to as BCL2-associated athanogene. It enhances the anti-apoptotic effects of BCL2 and represents a link between growth factor receptors and anti-apoptotic mechanisms. Multiple protein isoforms are encoded by this mRNA through the use of a non-AUG (CUG) initiation codon, and three alternative downstream AUG initiation codons. A related pseudogene has been defined on chromosome X.
BAG family molecular chaperone regulator 1
, Bcl-2 associating athanogene-1 protein
, Bcl-2-binding protein
, glucocortoid receptor-associated protein RAP46
, receptor-associated protein, 46-KD
, bcl2-associated athanogene
, BCL2-associated athanogene
, bcl-2-associated athanogene 1
, hydroxysteroid (17-beta) dehydrogenase 3